Morningside & Shenzhen Capital Boost Inflammatory Disease Therapies
20 Mar 2025
US$ 20.00
Morningside Ventures (Morningside) and Shenzhen Capital Group (SCG) have made a follow-on investment in the ......
Related Publications
Subscribers’ Weekly ending 13 Jun 2025...
Listen to Rest of Asia/Rest of the World Investments (Subscribers' Weekly 13 Jun 2025)...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.